Cargando…

Analysis of Clinical Characteristics of Patients with Recurrent Cytomegalovirus Retinitis after Hematopoietic Stem Cell Transplantation

Objective: To analyze and summarize the clinical and imaging characteristics of patients with cytomegalovirus retinitis (CMVR) relapse after hematopoietic stem cell transplantation (HSCT). Methods: This retrospective case series study recruited patients with CMVR after HSCT. The study compared the p...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiaona, Lu, Yao, Li, Haiping, Ma, Zhizhong, Hong, Jing, Wang, Changguan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142787/
https://www.ncbi.nlm.nih.gov/pubmed/37109025
http://dx.doi.org/10.3390/jpm13040639
_version_ 1785033696085016576
author Wang, Xiaona
Lu, Yao
Li, Haiping
Ma, Zhizhong
Hong, Jing
Wang, Changguan
author_facet Wang, Xiaona
Lu, Yao
Li, Haiping
Ma, Zhizhong
Hong, Jing
Wang, Changguan
author_sort Wang, Xiaona
collection PubMed
description Objective: To analyze and summarize the clinical and imaging characteristics of patients with cytomegalovirus retinitis (CMVR) relapse after hematopoietic stem cell transplantation (HSCT). Methods: This retrospective case series study recruited patients with CMVR after HSCT. The study compared the patients with stable lesions and CMV-negative aqueous humor after treatment with those with relapse lesions and a CMV DNA load in aqueous humor which had increased again after treatment. The observation indexes were basic clinical information, best-corrected visual acuity, wide-angle fundus photography, optical coherence tomography (OCT), blood CD4(+) T lymphocyte count, and aqueous humor CMV load of the patients. We summarized the data and statistically analyzed the differences between the relapse and non-relapse groups, as well as the correlations of the observed indicators. Results: The study recruited 52 patients with CMVR (82 eyes) after HSCT, of whom 11 patients (15 eyes) had recurrence after treatment (21.2%). The recurrence interval was 6.4 ± 4.9 months. The final best-corrected visual acuity of recurrent patients was 0.3 ± 0.3. The number of CD4(+) T lymphocytes in recurrence patients at the time of onset was 126.7 ± 80.2/mm(3). The median CMV DNA load detected in aqueous humor at the time of recurrence was 8.63 × 10(3) copies/mL. There was a significant difference in the CD4(+) T lymphocyte count between the recurrence and the non-recurrence groups at onset. The onset of visual acuity in recurrence patients was significantly correlated with final visual acuity and recurrence lesion area. The fundus of recurred CMVR showed increased marginal activity of the original stable lesion. Concurrently, yellow-white new lesions appeared around the stable, atrophic, and necrotic lesions. OCT showed new diffuse hyperreflexic lesions in the retinal neuroepithelial layer near the old lesions. Inflammatory punctate hyperreflexes were observed in the vitreous, with vitreous liquefaction and contraction. Conclusion: This study suggests that the clinical features, fundus manifestations, and imaging features of CMVR recurrence after HSCT are different from those at the initial onset. Patients should be closely followed up after their condition is stable to be alert for CMVR recurrence.
format Online
Article
Text
id pubmed-10142787
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-101427872023-04-29 Analysis of Clinical Characteristics of Patients with Recurrent Cytomegalovirus Retinitis after Hematopoietic Stem Cell Transplantation Wang, Xiaona Lu, Yao Li, Haiping Ma, Zhizhong Hong, Jing Wang, Changguan J Pers Med Article Objective: To analyze and summarize the clinical and imaging characteristics of patients with cytomegalovirus retinitis (CMVR) relapse after hematopoietic stem cell transplantation (HSCT). Methods: This retrospective case series study recruited patients with CMVR after HSCT. The study compared the patients with stable lesions and CMV-negative aqueous humor after treatment with those with relapse lesions and a CMV DNA load in aqueous humor which had increased again after treatment. The observation indexes were basic clinical information, best-corrected visual acuity, wide-angle fundus photography, optical coherence tomography (OCT), blood CD4(+) T lymphocyte count, and aqueous humor CMV load of the patients. We summarized the data and statistically analyzed the differences between the relapse and non-relapse groups, as well as the correlations of the observed indicators. Results: The study recruited 52 patients with CMVR (82 eyes) after HSCT, of whom 11 patients (15 eyes) had recurrence after treatment (21.2%). The recurrence interval was 6.4 ± 4.9 months. The final best-corrected visual acuity of recurrent patients was 0.3 ± 0.3. The number of CD4(+) T lymphocytes in recurrence patients at the time of onset was 126.7 ± 80.2/mm(3). The median CMV DNA load detected in aqueous humor at the time of recurrence was 8.63 × 10(3) copies/mL. There was a significant difference in the CD4(+) T lymphocyte count between the recurrence and the non-recurrence groups at onset. The onset of visual acuity in recurrence patients was significantly correlated with final visual acuity and recurrence lesion area. The fundus of recurred CMVR showed increased marginal activity of the original stable lesion. Concurrently, yellow-white new lesions appeared around the stable, atrophic, and necrotic lesions. OCT showed new diffuse hyperreflexic lesions in the retinal neuroepithelial layer near the old lesions. Inflammatory punctate hyperreflexes were observed in the vitreous, with vitreous liquefaction and contraction. Conclusion: This study suggests that the clinical features, fundus manifestations, and imaging features of CMVR recurrence after HSCT are different from those at the initial onset. Patients should be closely followed up after their condition is stable to be alert for CMVR recurrence. MDPI 2023-04-07 /pmc/articles/PMC10142787/ /pubmed/37109025 http://dx.doi.org/10.3390/jpm13040639 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Wang, Xiaona
Lu, Yao
Li, Haiping
Ma, Zhizhong
Hong, Jing
Wang, Changguan
Analysis of Clinical Characteristics of Patients with Recurrent Cytomegalovirus Retinitis after Hematopoietic Stem Cell Transplantation
title Analysis of Clinical Characteristics of Patients with Recurrent Cytomegalovirus Retinitis after Hematopoietic Stem Cell Transplantation
title_full Analysis of Clinical Characteristics of Patients with Recurrent Cytomegalovirus Retinitis after Hematopoietic Stem Cell Transplantation
title_fullStr Analysis of Clinical Characteristics of Patients with Recurrent Cytomegalovirus Retinitis after Hematopoietic Stem Cell Transplantation
title_full_unstemmed Analysis of Clinical Characteristics of Patients with Recurrent Cytomegalovirus Retinitis after Hematopoietic Stem Cell Transplantation
title_short Analysis of Clinical Characteristics of Patients with Recurrent Cytomegalovirus Retinitis after Hematopoietic Stem Cell Transplantation
title_sort analysis of clinical characteristics of patients with recurrent cytomegalovirus retinitis after hematopoietic stem cell transplantation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142787/
https://www.ncbi.nlm.nih.gov/pubmed/37109025
http://dx.doi.org/10.3390/jpm13040639
work_keys_str_mv AT wangxiaona analysisofclinicalcharacteristicsofpatientswithrecurrentcytomegalovirusretinitisafterhematopoieticstemcelltransplantation
AT luyao analysisofclinicalcharacteristicsofpatientswithrecurrentcytomegalovirusretinitisafterhematopoieticstemcelltransplantation
AT lihaiping analysisofclinicalcharacteristicsofpatientswithrecurrentcytomegalovirusretinitisafterhematopoieticstemcelltransplantation
AT mazhizhong analysisofclinicalcharacteristicsofpatientswithrecurrentcytomegalovirusretinitisafterhematopoieticstemcelltransplantation
AT hongjing analysisofclinicalcharacteristicsofpatientswithrecurrentcytomegalovirusretinitisafterhematopoieticstemcelltransplantation
AT wangchangguan analysisofclinicalcharacteristicsofpatientswithrecurrentcytomegalovirusretinitisafterhematopoieticstemcelltransplantation